reports
Snap Inc: 1 director
A director at Snap Inc sold 2,737,150 shares at 7.305USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
CPS Announces Second Quarter 2025 Earnings
CPS Announces Second Quarter 2025 Earnings Revenues of $109.8 million compared to $95.9 million in the prior year periodPretax income of $7.0 million compared to $6.7 million in the prior year periodRecord high shareholder’s equity- first time over $300 millionNew contract purchases of $433.0 million in the quarter LAS VEGAS, NV, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) today announced earnings of $4.8 million, or $0.20 per diluted share, for its second quarter ended June 30, 2025. This represents an increase compared to ...
CPS to Host Conference Call on Second Quarter 2025 Earnings
CPS to Host Conference Call on Second Quarter 2025 Earnings Las Vegas, Nevada, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) today announced that it will hold a conference call on Tuesday, August 12, 2025 at 1:00 p.m. ET to discuss its second quarter 2025 operating results. Those wishing to participate can pre-register for the conference call at the following link . Registered participants will receive an email containing conference call details for dial-in options. To avoid delays, we encourage participants to dial into the c...
KALA BIO Reports Second Quarter 2025 Financial Results and Provides Co...
KALA BIO Reports Second Quarter 2025 Financial Results and Provides Corporate Update -- Completed patient enrollment in Phase 2b CHASE trial of KPI-012 in Persistent Corneal Epithelial Defect (PCED); topline data expected at the end of September 2025 -- -- Cash resources of $31.9 million as of June 30, 2025, expected to fund operations into 1Q 2026 -- ARLINGTON, Mass., Aug. 08, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases ...
KALA BIO to Present at H.C. Wainwright 5th Annual Ophthalmology Virtua...
KALA BIO to Present at H.C. Wainwright 5th Annual Ophthalmology Virtual Conference ARLINGTON, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, today announced that members of management will present at the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference being held virtually on Wednesday, August 13, 2025. A pre-recorded presentation will be made available beginning on Wednesday, August 13, ...
CPS Announces $418.33 Million Senior Subordinate Asset-Backed Securiti...
CPS Announces $418.33 Million Senior Subordinate Asset-Backed Securitization LAS VEGAS, Nevada, July 28, 2025 (GLOBE NEWSWIRE) -- Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) announced the closing of its third term securitization in 2025 on Monday July 28, 2025. The transaction is CPS's 56th senior subordinate securitization since the beginning of 2011 and the 39th consecutive securitization to receive a triple “A” rating from at least two rating agencies on the senior class of notes. In the transaction, qualified institutional buyers purchased $418.33 millio...
Range Announces Second Quarter 2025 Results
Range Announces Second Quarter 2025 Results FORT WORTH, Texas, July 22, 2025 (GLOBE NEWSWIRE) -- RANGE RESOURCES CORPORATION (NYSE: RRC) today announced its second quarter 2025 financial results. Second Quarter 2025 Highlights – Cash flow from operating activities of $336 millionCash flow from operations, before working capital changes, of $301 millionRepurchased $53 million of shares, paid $21 million in dividends, and reduced net debt to $1.2 billionCapital spending was $154 million, approximately 23% of the annual 2025 budgetRealized price, including hedges, was $3.49 per mcfeNatura...
Great Southern Bancorp, Inc. Reports Preliminary Second Quarter Earnin...
Great Southern Bancorp, Inc. Reports Preliminary Second Quarter Earnings of $1.72 Per Diluted Common Share Preliminary Financial Results and Business Update for the Quarter Ended June 30, 2025 SPRINGFIELD, Mo., July 16, 2025 (GLOBE NEWSWIRE) -- Great Southern Bancorp, Inc. (the “Company”) (NASDAQ:GSBC), the holding company for Great Southern Bank (the “Bank”), today reported that preliminary earnings for the three months ended June 30, 2025, were $1.72 per diluted common share ($19.8 million net income) compared to $1.45 per diluted common share ($17.0 million net income) for the three ...
KALA BIO Announces Completion of Enrollment in CHASE Clinical Trial Ev...
KALA BIO Announces Completion of Enrollment in CHASE Clinical Trial Evaluating KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED) -- Topline results from the CHASE trial expected by end of Q3 2025 -- -- Potential for CHASE to serve as a pivotal trial in support of a Biologics License Application (BLA) submission, contingent on positive results -- ARLINGTON, Mass., July 09, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and...
KALA BIO to Host Virtual Key Opinion Leader (KOL) Event to Discuss the...
KALA BIO to Host Virtual Key Opinion Leader (KOL) Event to Discuss the Potential of KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED) ARLINGTON, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, today announced that the Company will host a webcast event with Key Opinion Leaders (KOLs) to discuss the potential of KPI-012 for the treatment of persistent corneal epithelial defect (P...
Range Announces Conference Call to Discuss Second Quarter 2025 Financi...
Range Announces Conference Call to Discuss Second Quarter 2025 Financial Results FORT WORTH, Texas, July 03, 2025 (GLOBE NEWSWIRE) -- RANGE RESOURCES CORPORATION (NYSE: RRC) announced today that its second quarter 2025 financial results news release will be issued Tuesday, July 22 after the close of trading on the New York Stock Exchange. A conference call to review the financial results is scheduled for Wednesday, July 23 at 9:00 a.m. ET (8:00 a.m. CT). A webcast of the call may be accessed at . The webcast will be archived for replay on the Company's website until August 23, 2025. RAN...
Range Resources Publishes 2024-2025 Corporate Sustainability Report
Range Resources Publishes 2024-2025 Corporate Sustainability Report FORT WORTH, Texas, June 26, 2025 (GLOBE NEWSWIRE) -- RANGE RESOURCES CORPORATION (NYSE: RRC) today published its 2024-2025 Corporate Sustainability Report. The report illustrates the Company’s focus on sustainably developing the energy the world needs. “Operational excellence and environmental responsibility go hand in hand - delivering sustainable performance today, and long-term value well into the future,” said Dennis Denger, the Company’s CEO, “the natural gas and natural gas liquids we produce in Pennsylvania are ec...
Great Southern Bancorp, Inc. Announces Second Quarter 2025 Preliminary...
Great Southern Bancorp, Inc. Announces Second Quarter 2025 Preliminary Earnings Release Date and Conference Call SPRINGFIELD, Mo., June 20, 2025 (GLOBE NEWSWIRE) -- Great Southern Bancorp, Inc. (NASDAQ:GSBC), the holding company for Great Southern Bank, expects to report second quarter preliminary earnings after the market closes on Wednesday, July 16, 2025, and host a conference call on Thursday, July 17, 2025, at 2:00 p.m. Central Time (3:00 p.m. Eastern Time). The call will be available live or later in a recorded version at the Company’s Investor Relations website, . Participant...
Great Southern Bancorp, Inc. announces quarterly dividend of $0.40 per...
Great Southern Bancorp, Inc. announces quarterly dividend of $0.40 per common share SPRINGFIELD, Mo., June 18, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Great Southern Bancorp, Inc. (NASDAQ:GSBC), the holding company for Great Southern Bank, declared a $0.40 per common share dividend for the second quarter of the calendar year ending December 31, 2025. The dividend will be payable on July 15, 2025, to stockholders of record on June 30, 2025. This dividend represents the 142nd consecutive quarterly dividend paid by the Company to common stockholders. About Great Southern Bank H...
Range Declares Quarterly Dividend
Range Declares Quarterly Dividend FORT WORTH, Texas, May 30, 2025 (GLOBE NEWSWIRE) -- RANGE RESOURCES CORPORATION (NYSE: RRC) today announced that its Board of Directors declared a quarterly cash dividend on its common stock for the second quarter. A dividend of $0.09 per common share is payable on June 27, 2025 to stockholders of record at the close of business on June 13, 2025. RANGE RESOURCES CORPORATION (NYSE: RRC) is a leading U.S. independent natural gas and NGL producer with operations focused in the Appalachian Basin. The Company is headquartered in Fort Worth, Texas. More infor...
KALA BIO to Present at Jefferies Global Healthcare Conference
KALA BIO to Present at Jefferies Global Healthcare Conference ARLINGTON, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, today announced that members of management will present at the Jefferies Global Healthcare Conference being held in New York, NY on Thursday, June 5, 2025 at 1:25 p.m. ET. Management will also be available for one-on-one meetings on Thursday, June 5, 2025. To access the webcast and...
- Dan Salmon
KALA BIO Reports First Quarter 2025 Financial Results and Provides Cor...
KALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate Update -- Ongoing patient enrollment in Phase 2b CHASE trial of KPI-012 in Persistent Corneal Epithelial Defect (PCED); topline data anticipated in 3Q 2025 -- -- Cash resources of $42.2 million as of March 31, 2025, expected to fund operations into 1Q 2026 -- ARLINGTON, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye...
CPS Announces First Quarter 2025 Earnings
CPS Announces First Quarter 2025 Earnings Revenues of $106.9 million compared to $91.7 million in the prior year periodNet income of $4.7 million, or $0.19 per diluted shareTotal portfolio balance of $3.615 billion, highest in company historyNew contract purchases of $451.2 million LAS VEGAS, NV, May 12, 2025 (GLOBE NEWSWIRE) -- Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) today announced earnings of $4.7 million, or $0.19 per diluted share, for its first quarter ended March 31, 2025. This compares to a net income of $4.6 million, or $0.19 per diluted share, ...
CPS Announces $419.95 Million Senior Subordinate Asset-Backed Securiti...
CPS Announces $419.95 Million Senior Subordinate Asset-Backed Securitization LAS VEGAS, Nevada, May 12, 2025 (GLOBE NEWSWIRE) -- Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) announced the closing of its second term securitization in 2025 on Monday May 12, 2025. The transaction is CPS's 55th senior subordinate securitization since the beginning of 2011 and the 38th consecutive securitization to receive a triple “A” rating from at least two rating agencies on the senior class of notes. In the transaction, qualified institutional buyers purchased $419....
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.